Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: Results from a phase Ib/IIa study

  1. Martin, M.
  2. Fumoleau, P.
  3. Dewar, J.A.
  4. Albanell, J.
  5. Limentani, S.A.
  6. Campone, M.
  7. Chang, J.C.
  8. Patre, M.
  9. Strasak, A.
  10. de Haas, S.L.
  11. Xu, J.
  12. Garcia-Saenz, J.A.
Zeitschrift:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Datum der Publikation: 2016

Ausgabe: 27

Nummer: 7

Seiten: 1249-1256

Art: Artikel

DOI: 10.1093/ANNONC/MDW157 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus